Sign In
Buy RCEL
$4.16
-0.0300 (-0.716%)
At Close: Jun 03, 2026
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Prepared Remarks Transcript
07:31pm, Wednesday, 03'rd Jun 2026
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Prepared Remarks Transcript
AVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth Transcript
09:03am, Thursday, 21'st May 2026
AVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth Transcript
AVITA Medical to Host Investor Webinar Briefing
06:00pm, Sunday, 17'th May 2026
VALENCIA, Calif., May 17, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholder
Avita Medical Q1 Earnings Call Highlights
11:07pm, Thursday, 14'th May 2026
Avita Medical NASDAQ: RCEL reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook as management said reimbursement conditions for its RECELL product are normalizing and demand
AVITA Medical, Inc. (RCEL) Q1 2026 Earnings Call Transcript
07:30pm, Thursday, 14'th May 2026
AVITA Medical, Inc. (RCEL) Q1 2026 Earnings Call Transcript
AVITA Medical Reports First Quarter 2026 Financial Results
04:05pm, Thursday, 14'th May 2026
VALENCIA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,
AVITA Medical Names Cary Vance as Chief Executive Officer
08:50am, Thursday, 30'th Apr 2026
Board appoints Cary Vance as President and Chief Executive Officer Follows successful interim tenure and thorough search process by the Board Jan Stern Reed elected as Chair of the AVITA Medical Board
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
04:05pm, Wednesday, 29'th Apr 2026
RECELL GO® receives regulatory clearance in Australia and New Zealand, enabling commercialization across both markets RECELL GO is AVITA Medical's next-generation system that automates and standardiz
AVITA Medical to Announce First Quarter 2026 Financial Results
04:10pm, Thursday, 23'rd Apr 2026
VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that it will report its first quart
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc. - RCEL
04:30pm, Tuesday, 21'st Apr 2026
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical Inc. (“AVITA Medical” or the “Company”) (NASDAQ: RCEL). Such investor
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript
09:01pm, Thursday, 16'th Apr 2026
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
09:20am, Wednesday, 15'th Apr 2026
Recognition highlights pioneering contributions to modern burn care including development of RECELL ® Spray-On Skin™ VALENCIA, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASD
Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?
08:11am, Wednesday, 15'th Apr 2026
Avita Medical (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near ter
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
07:45am, Tuesday, 14'th Apr 2026
Cohealyx interim data show ~20-day reduction in time to graft vs benchmark, with strong investigator satisfaction and consistent performance across wounds.
AVITA Medical, Inc. Investigated by the Portnoy Law Firm
09:00am, Monday, 13'th Apr 2026
LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AVITA Medical, Inc. , (“ AVITA " or the "Company") ( NASDAQ : RCEL ) investors that the firm has initiated an investigati
